The described clinical case is notable for the early diagnosis of dermatomyositis. Timely diagnosis and correct selection of therapy are fundamental to reducing the incidence of various complications and improving the quality of life of patients with this pathology.

dermatomyositis, arthralgia, myalgia, autoimmune disease.

Orlova E.V. et al. Dermatomyositis: Clinical Case and Literature Review // Russian Medical Journal. – 2017. – No. 11. – P. 850–852.

Beel A.J. et al. Ground-glass opacity heralding invasive lung adenocarcinoma with prodromal dermatomyositis: a case report // J. Cardiothorac. Surg. – 2018. – Vol. 13, No. 1. – P. 20.

Bendewald M.J. et al. Incidence of Dermatomyositis and Clinically Amyopathic Dermatomyositis: A Population-Based Study in Olmsted County, Minnesota // Arch. Dermatol. – 2010. – Vol. 146, No. 1. – P. 26–30.

Bernet L.L. et al. Ovoid palatal patch in dermatomyositis: a novel finding associated with anti-TIF1γ (p155) antibodies // JAMA Dermatol. – 2016. – Vol. 152, No. 9. – P. 1049–1051.

Buchbinder R., Hill C.L. Malignancy in patients with inflammatory myopathy // Curr. Rheumatol. Rep. – 2002. – Vol. 4, No. 5. – P. 415–426.

Cassius C. et al. Biomarkers in adult dermatomyositis: tools to help the diagnosis and predict the clinical outcome// J. Immunol. Res. – 2019. – Vol. 2019. – P. 9141420.

Dalakas M.C. Inflammatory muscle diseases // N. Engl. J. Med. – 2015. – Vol. 372, No. 18. – P. 1734–1747.

Gunawardena H., Betteridge Z.E., McHugh N.J. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression // Rheumatology (Oxford). – 2009. – Vol. 48, No. 6. – P. 607–612.

Hill C.L. et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study // Lancet. – 2001. – Vol. 357, No. 9250. – P. 96–100.

Love L.A. et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups // Medicine (Baltimore). – 1991. – Vol. 70, No. 6. – P. 360–374.

Marvi U., Chung L., Fiorentino D.F. Clinical presentation and evaluation of dermatomyositis // Indian J. Dermatol. – 2012. – Vol. 57, No. 5. – P. 375–381.

Mukhammadieva S.M. Efficacy and safety of anti-inflammatory treatment in ankylosing spondyloarthritis // British View. – 2023. – Vol. 8, Issue 7. – P. 24–31.

Nagaraju K., Lundberg I.E. Polymyositis and dermatomyositis: pathophysiology // Rheum. Dis. Clin. North Am. – 2011. – Vol. 37, No. 2. – P. 159–171.

Pulatova Sh., Nabiyeva D., Abduazizova N. et al. Clinical and pathogenetic values of disorders of mineral metabolism in ankylosing spondylitis // Philosophical Readings. – 2022. – Vol. XIII, No. 4. – P. 20–28.

Tanimoto K. et al. Classification criteria for polymyositis and dermatomyositis // J. Rheumatol. – 1995. – Vol. 22, No. 4. – P. 668–674.